Merck

By  Brian Dolan 07:00 am August 28, 2012
Digital health accelerator Rock Health's investor partners have upped the amount of seed funding they will invest in startups that participate in the program from $20,000 to $100,000. The startups will each receive a total of $100,000 from Kleiner Perkins Caufield & Byers (KPCB), Mohr Davidow Ventures, Aberdare Ventures, and the Mayo Clinic. Rock Health, which is itself a non-profit, will...
By  Brian Dolan 04:43 am June 26, 2012
"The reality of today’s funding environment for digital health entrepreneurs is that it’s traditional tech investors who have the lion’s share of the money, while most long-time healthcare investors are on the ropes, contending with fleeing LPs and at least the perception of disappointing returns," pharmaceutical company executive David Shaywitz writes in his most recent (must-read) column for...
By  Brian Dolan 10:38 am January 5, 2012
Physicians Interactive, which offers the popular professional medical app Skyscape, announced this week that Merck will invest up to $17 million in the company via its Global Health Innovation Fund (GHIF). Initially, the financing includes $8.5 million, but depending on whether the company meets certain milestones, Merck's GHIF could bump the investment up another $8.5 million for a total of $17...
By  Chris Gullo 09:37 am November 9, 2011
Merck Canada announced this month a deal with Mihealth to promote its PHR offering to Canadian doctors. According to Mihealth, which has an exclusive license to Diversinet's MobiSecure platform in Canada, its PHR data is validated by a physician once a year to ensure accuracy of the health information. Mihealth's PHR is available for iOS, Android, BlackBerry and Windows smartphones. The software...
By  Brian Dolan 02:02 pm January 19, 2011
We mentioned a report last week from the Digital Pharma Blog that Pfizer, Johnson & Johnson and Merck had each removed apps from the Apple AppStore in recent months. While many others covering this story attributed the move to a potential rethinking on the value of apps, the Digital Pharma Blog attributes many of the withdrawals to mergers the companies went through during the past two years...